Rigel Pharmaceuticals Inc (RIGL) stock news · P/E 2.7, rev $294.3M
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
This RIGL news page leads with what Rigel Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for RIGL yet. We will not pad this page with generic market recap.
Latest reported RIGL revenue for 2025-12-31 was $294.3M. Net income was $367.0M. Revenue was up 64.1% from 2024-12-31 to 2025-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 2.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RIGL stock page; for the tape open the quote page.
RIGL stock news FAQ
What are RIGL's latest revenue and net income?
Latest cached Rigel Pharmaceuticals Inc (RIGL) revenue for Dec 31, 2025 was $294.3M. Net income was $367.0M. Statements: https://lician.com/financials/rigl
How did RIGL revenue change from the prior cached period?
Cached Rigel Pharmaceuticals Inc (RIGL) revenue was up 64.1% from $179.3M (Dec 31, 2024) to $294.3M (Dec 31, 2025). Statements: https://lician.com/financials/rigl
What is RIGL's P/E ratio?
Rigel Pharmaceuticals Inc (RIGL) trailing P/E is 2.72 on the latest cached fundamentals snapshot.
What is RIGL's market cap?
Rigel Pharmaceuticals Inc (RIGL) market cap is $338.3M on the latest cached fundamentals snapshot.
What kind of company is RIGL?
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Where is RIGL stock news listed?
Cached stock news for Rigel Pharmaceuticals Inc (RIGL) is listed at https://lician.com/news/rigl. Filings: https://lician.com/sec/rigl
Not investment advice.